electroCore Donates gammaCore Sapphire for Real World Evaluation of nVNS in Trauma Among Israelis
November 19, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it has donated 20 gammaCore...
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21
November 14, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
electroCore Announces Third Quarter 2024 Financial Results
November 13, 2024 16:01 ET
|
electroCore, Inc.
Record quarterly revenues driven by 75% YoY growth of Rx gammaCore™ in the VA/DoD and 147% increase in Truvaga™ sales Company to host a conference call and webcast today, November 13, 2024 at...
electroCore to Announce Third Quarter September 30, 2024 Financial Results on Wednesday, November 13, 2024
October 23, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...
electroCore to Participate in Upcoming Investor Conferences
September 26, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
electroCore Engages FNK IR to Execute Expanded Investor Relations Program
September 24, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it has engaged FNK IR, an...
electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in...
electroCore Announces Second Quarter 2024 Financial Results
August 07, 2024 16:01 ET
|
electroCore, Inc.
Seventh consecutive record quarterly net sales of $6.1 million, an increase of 73% over second quarter 2023 Company to host a conference call and webcast today, August 7, 2024 at 4:30 PM EST ...
electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024
July 31, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...
electroCore to Join Russell Microcap® Index
June 11, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that its stock is on the...